Prime award
AMGEN USA INC · Department of Health and Human Services
TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
Current value$714M
Obligated to date$0
Months remaining72
Sign in to mark this as watching, pursuing, or passed — and to be told when its end date changes.
Award record
| Field | Value |
|---|---|
| Recipient | AMGEN USA INC |
| Awarding agency | Department of Health and Human Services |
| NAICS | 541714 |
| PSC | AN13 |
| Place of performance | CA |
| Period | → Sep 29, 2032 |
| Set-aside | NO SET ASIDE USED. |
| Competition | A |
| Offers received | 1 offer |
| Vehicle | Standalone |
Data & sources
Record as published by USAspending.gov, vintage FY2021–FY2025 full archives · USAspending.gov, retrieved Aug 6, 2026. Values change as modifications are reported; obligations may be negative when work is de-obligated.